E. Brunt

Epidemiology · 2000–2018

A researcher in the Science corpus: 18 papers; trusts 9 researchers and is trusted by 32 researchers here, as inferred from the citation graph.

Subfields

• Epidemiology — 238 citations into it; #78 of 2,148 by trust here, #42 by citations
• Hepatology — 112 citations into it; #5 of 151 by trust here, #5 by citations
• Pathology and Forensic Medicine — 40 citations into it; #9 of 414 by trust here, #96 by citations

Whom E. Brunt trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. D. Kleiner
2. H. B. EL‐SERAG
3. A. Sanyal
4. Jordi Bruix1 , 2
5. B. Neuschwander‐Tetri

Who trusts E. Brunt overall

1. J. Clark
2. Zhaoyu Li
3. S. Dasarathy
4. M. Webb
5. Z. Younossi
6. D. Kleiner
7. Luis B. Agellon
8. Jaividhya Dasarathy
9. H. Yeshua
10. N. Chalasani

Papers from E. Brunt's perspective

Ordered by how strongly the researchers E. Brunt trusts endorse each paper. Same corpus, a different order for every researcher.

1. AGA technical review on nonalcoholic fatty liver disease. (Gastroenterology)
2. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. (Gastroenterology)
3. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity (Hepatology)
4. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes (Hepatology)
5. ENDPOINTS AND CLINICAL TRIAL DESIGN FOR NONALCOHOLIC STEATOHEPATITIS (Hepatology)
6. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. (Gastroenterology)
7. Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality (Hepatology)
8. Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease (Gastroenterology)
9. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. (New England Journal of Medicine)
10. NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States (Hepatology)

Their papers

• A unique role for autophagy and Atg16L1 in Paneth cells in murine and human intestine (2008) — 1,536 citations
• Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. (2012) — 830 citations
• AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma (2007) — 646 citations
• Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR‐γ ligand rosiglitazone (2003) — 766 citations
• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2018) — 6,253 citations
• Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial (2014) — 2,063 citations
• The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (2012) — 2,216 citations
• The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. (2012) — 1,723 citations
• Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents (2011) — 1,028 citations
• Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings (2011) — 1,153 citations
• Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis (2010) — 3,032 citations
• Nonalcoholic fatty liver disease: pathology and pathogenesis. (2010) — 841 citations
• Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia (2009) — 796 citations
• Pathology of nonalcoholic fatty liver disease. (2007) — 659 citations
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease (2005) — 10,109 citations
• Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers (2004) — 700 citations
• Nonalcoholic Steatohepatitis: Definition and Pathology (2001) — 1,008 citations
• Humanized xenobiotic response in mice expressing nuclear receptor SXR (2000) — 696 citations